Description
Seasonix 60 ml Oral Solution contains Levocetirizine Dihydrochloride, a potent non-sedating antihistamine developed by Incepta Pharmaceuticals Ltd. . It is primarily indicated for the treatment of symptoms associated with allergic conditions such as perennial allergic rhinitis, seasonal allergic rhinitis, and chronic idiopathic urticaria. Levocetirizine is the active (Levo) isomer of cetirizine and exhibits twice the affinity for H1 receptors compared to cetirizine, providing rapid and long-lasting relief from allergy symptoms with once-daily dosing. The recommended dosage varies by age: for adults and children aged 12 years and older, 5 mg once daily; for children aged 6 to 11 years, 2.5 mg (½ tablet or 1 teaspoon oral solution) once daily; and for children aged 6 months to 5 years, 1.25 mg (½ teaspoon oral solution) once daily. In patients with renal impairment, dose adjustments are necessary. Seasonix is generally well-tolerated, with potential side effects including headache, dry mouth, fatigue, and skin rash. It is contraindicated in individuals with hypersensitivity to levocetirizine, cetirizine, or hydroxyzine, and should be used with caution in patients with renal impairment. Levocetirizine is excreted in breast milk; therefore, its use during breastfeeding is not recommended. As a non-sedating antihistamine, Seasonix is less likely to cause drowsiness compared to first-generation antihistamines, but caution should still be exercised when engaging in activities requiring mental alertness. It is advisable to store Seasonix at a temperature not exceeding 30°C in a dry place, protected from light.
.jpg)
.webp)
.jpg)
.jpeg)
 400MG.jpg)
.webp)
.jpg)
.jpg)
.jpeg)
.jpg)
.png)
 100 IU 3 ML.webp)
.jpeg)
.jpeg)
.webp)
.jpg)
.jpg)
.jpg)
Change Language